Author: Scarlett Publish Time: 2023-08-21 Origin: Site
(Bangkok, Thailand, 18 August, 2023) The Medlab Asia 2023 has drawn its curtains, leaving behind a trail of innovation, collaboration, and impactful connections. As we pause to reflect on this event, we are thrilled to share our journey and the significant impact it has made on our presence in the South East Asia region.
This year, Goldsite showcase at booth# H6.A35. Our participation reaffirms our commitment to delivering innovative and efficient solutions that help shape a healthier and more sustainable future. We look forward to the opportunity to engage with attendees, from industry peers to potential clients.
At Goldsite’s booth #H6.A35, Our team of professionals conduct live demonstrations of the featured Point-of-Care Testing (POCT) solutions, GPP-100, A1c Go, FIA Go, providing attendees with a hands-on experience of their functionalities. Our experts will also be on hand to dive into the features of these solutions in detail, as well as to address any questions regarding their implementation and potential benefits.
The rapid pace of urbanization across South East Asia has resulted in increased demand for quality healthcare services. Robust healthcare infrastructure is essential to cater to the growing urban populations, ensuring that healthcare remains accessible and efficient.
FIA GO’s compact design, user-friendly interface, and rapid result delivery make it ideally suited for clinics, hospitals, and mobile testing units, with a wide range of assays covering hormone, thyroid, inflammation and diabetes disease. This aspect is particularly vital for South East Asia, where changing lifestyles in the region have led to a surge in non-communicable diseases such as diabetes, heart disease, and obesity. Addressing these concerns requires comprehensive healthcare solutions that encompass preventive measures, early detection, and effective treatment strategies.
Diabetes poses a significant health challenge worldwide, recognizing the unique healthcare needs and challenges in these regions, we've designed our HbA1c series specifically for point-of-care settings, the A1c Go POCT analyzer based on boronate affinity chromatography methodology.
The region's remarkable economic growth has opened doors to new opportunities. However, this growth comes with its share of healthcare accessibility disparities. Bridging the gap between economic progress and equitable healthcare access remains a fundamental challenge that needs to be addressed.
This requites that the medical instruments are not only should swift and precise but also can be easily deployable and accessible across both urban centers and remote locations. Our HbA1c series has earned both NGSP (National Glycohemoglobin Standardization Program) and IFCC (International Federation of Clinical Chemistry and Laboratory Medicine) certifications, ensuring its accuracy and consistency across varied clinical settings.
By bridging the gap between advanced diagnostics and point-of-care settings, Goldsite aims to democratize access to high-quality healthcare across both continents, contributing to more robust and equitable health systems.
The exhibition wasn't just about showcasing our solutions; it was an opportunity to connect with our peers, industry experts, and most importantly, our clients and distributors.
Our booth served as a hub of interaction, where we engaged in insightful conversations about the future of our industry. We were particularly excited to engage with our existing clients, strengthening our partnerships and learning how our solutions have contributed to their success stories.
One of the most rewarding outcomes of the exhibition has been the reinforcement of our partnerships with clients and distributors in the South East Asia region. The face-to-face interactions allowed us to better understand the needs and challenges faced by our partners, fostering an environment of mutual growth and collaboration.
We extend our heartfelt gratitude to all who visited our booth, engaged in enlightening discussions, and contributed to the success of this event. Together, we're shaping the future of healthcare in South East Asia and beyond.
GOLDSITE DIGANOSTICS INC., established in 1999, is a leading manufacturer of IVD products dedicated to the healthcare sector. With over 23 years of expertise in the IVD industry, Goldsite has established itself as a trusted partner. With a team of experts in the field of diagnostics technology and a passion for improving healthcare, GOLDSITE strive to bring cutting-edge products to market that meet the evolving needs of health providers and patients. Engaged in R&D, manufacturing, and marketing of clinical laboratory devices and reagents, GOLDSITE has a portfolio of products covering specific proteins, chemistry, chemiluminescence, and POCT platform, as well as associated reagents. All products live up to global standards with CE marking and have been exported to more than 80+ countries.
Our vision is to deliver state-of-art solutions that enhance patient care and improve health outcomes. We are dedicated to providing healthcare professionals with the tools they need to deliver accurate and reliable diagnoses, while also making medical diagnostics more accessible and affordable for all. We aim to make a positive impact on global health and well-being.
For more about Goldsite, please visit our English Website at https://en.goldsite.com.cn/
Medlab Asia & Asia Health Exhibition & Congress brings together over 5,000 laboratory and healthcare professionals, C-level executives, distributors, scientists, clinicians from 65+ countries to discuss the latest aspects of medical, laboratory medicine and clinical research.
This year, the event takes place from 16-18 August in Halls 6-7 at IMPACT Exhibition Center in Bangkok, Thailand.